article · 2005
An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin
7 citationsDOI: https://doi.org/10.1007/s10637-005-2903-3
Article
Article detail, metadata, authors, and available full-text links.
Paper reader
Loading paper...